Stock Analysis

Agilent Technologies Full Year 2024 Earnings: In Line With Expectations

NYSE:A
Source: Shutterstock

Agilent Technologies (NYSE:A) Full Year 2024 Results

Key Financial Results

  • Revenue: US$6.51b (down 4.7% from FY 2023).
  • Net income: US$1.29b (up 4.0% from FY 2023).
  • Profit margin: 20% (up from 18% in FY 2023). The increase in margin was driven by lower expenses.
  • EPS: US$4.45 (up from US$4.22 in FY 2023).
earnings-and-revenue-growth
NYSE:A Earnings and Revenue Growth November 27th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Agilent Technologies Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Life Sciences industry in the US.

Performance of the American Life Sciences industry.

The company's shares are up 6.9% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Agilent Technologies' balance sheet and an in-depth analysis of the company's financial position.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.